Advertisement
Research Article| Volume 17, ISSUE 2, P123-127, September 1993

Continuous hormone replacement therapy with estradiol valerate and chlormadinone acetate in adjustable dosages. A preliminary study

  • Ursula Rauch
    Correspondence
    Correspondence to: Ursula Rauch, Division of gynecologic Endocrinology, Department of Obstetrics and Gynecology, Johann-Wolfgang-Goethe-University, Frankfurt am Main, Germany.
    Affiliations
    Division of gynecologic Endocrinology, Department of Obstetrics and Gynecology, Johann-WolfgangGoethe-University, Frankfurt am Main Germany
    Search for articles by this author
  • Hans-Dieter Taubert
    Affiliations
    Division of gynecologic Endocrinology, Department of Obstetrics and Gynecology, Johann-WolfgangGoethe-University, Frankfurt am Main Germany
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      A group of 62 peri- and postmenopausal women suffering from vasomotor disturbances and a variety of other symptoms were treated with estradiol valerate and chlormadinone acetate continuously using an adjustable dosage regimen. They obtained complete relief from vasomotor symptoms. The continuation rate was 81% after 1 year. In 18 patients the dose had to be adjusted because of breakthrough bleeding (n = 12), mastodynia (n = 3), and for the prevention of bone loss. In 11/12 patients breakhrough bleeding could be stopped by adjusting the dosage. This regimen seems to offer a more flexible approach to hormone replacement therapy (HRT) in the postmenopause than presently available combined preparations for continuous use.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Geola FL
        • Frumar AV
        • Tataryn IV
        • Lu KH
        • Hershman JM
        • Eggena P
        • Sambhi MP
        • Judd HL
        Biological effects of various doses of conjugated equine estrogens in postmenopausal women.
        J Clin Endocrinol Metab. 1980; 51: 620-625
        • Kuhl H
        • Taubert HD
        Das Klimakterium.
        in: Thieme, Stuttgart1987: 285 (ff.)
        • Andres R
        Mortality and obesity: The rationale for age specific height-weight tables.
        in: Andres R Bierman EL Hazzard WR Principles of Geriatric Medicine. McGraw-Hill, New York1985: 311-318
        • Jensen R
        • Riis BJ
        • Strom V
        • Christiansen C
        Long term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in postmenopausal women.
        Maturitas. 1989; 11: 117-128
        • Hohvik P
        • Sundsbak HP
        • Gaasemyr M
        • Sandvik L
        Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms.
        Maturitas. 1989; 11: 75-82
        • Mattsson LA
        • Cullberg G
        • Samsioe G
        Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints.
        Maturitas. 1982; 4: 95-102
        • Sporrong T
        • Samsioe G
        • Larsen S
        • Mattsson LA
        A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy.
        Maturitas. 1989; 11: 209-215
        • Caudron JH
        • Hendrickx
        Comparison of two equine oestrogen dydrogesterone regimens in the climacteric.
        Maturitas. 1989; 10: 133-141
        • Whitehead MI
        • Townsend PT
        • Pryse-Davies J
        • Path FRC
        • Ryder TA
        • King RJG
        Effects of estrogens and progestins on biochemistry and morphology of the postmenopausal endometrium.
        N Engl J Med. 1981; 305: 1599-1605
        • Neumann F
        The physiological action of progesterone and the pharmacological effects of progestogens — a short review.
        Postgrad Med J. 1978; 54: 11-24
        • Bottiglioni F
        • de Aloysio D
        • Nicoletti G
        • Mauloni M
        • Mantuano M
        • Motta R
        Physiopathological aspects of body overweight in the female climacteric.
        Maturitas. 1983; 5: 153-159
        • Rijpkema AHM
        • van der Sanden AA
        • Rijs AHC
        Effects of postmenopausal oestrogen-progestogen replacement on serum lipids and lipoproteins: a review.
        Maturitas. 1990; 12: 259-285